MOLECULAR MEDICINE REPORTS 12: 5568-5572, 2015

5568

1‑O‑acetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A549 human non‑small cell lung cancer cells FENG WANG1*, HONG LI2* and JIAN‑OU QIAO3 1

Department of Thoracic Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; 2 Department of Emergency, Shanghai Chest Hospital, Shanghai JiaoTong University School of Medicine; 3 Department of Respiratory Medicine, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, P.R. China Received November 9, 2013; Accepted June 17, 2014 DOI: 10.3892/mmr.2015.4042

Abstract. Non‑small‑cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases, with a 5‑year survival rate of

1‑O‑acetylbritannilactone combined with gemcitabine elicits growth inhibition and apoptosis in A549 human non‑small cell lung cancer cells.

Non‑small‑cell lung cancer (NSCLC) accounts for ~85% of all lung cancer cases, with a 5‑year survival rate of ...
671KB Sizes 0 Downloads 7 Views